Severity outcomes associated with SARS-CoV-2 XBB variants, an observational analysis
Eili Klein, Amary Fall, Julie M. Norton, Raghda E. Eldesouki, Omar Abdullah, Lijie Han, Madeline Yunker, Heba H. Mostafa
Abstract
The rapidity with which SARS-CoV-2 XBB variants rose to predominance has been alarming. We used a large cohort of patients diagnosed with Omicron infections between September 2022 and mid-February 2023 to evaluate the likelihood of admission or need for supplemental oxygen in patients infected with XBB variants. Our data showed no significant association between XBB or XBB.1.5 infections and admissions. Older age groups, lack of vaccination, immunosuppression and underlying heart, kidney, and lung disease showed significant associations with hospitalization.
Topics & Concepts
MedicineImmunosuppressionObservational studySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)CohortCoronavirus disease 2019 (COVID-19)VaccinationInternal medicineCohort study2019-20 coronavirus outbreakKidney diseaseDiseaseEmergency medicineImmunologyInfectious disease (medical specialty)VirologyOutbreakSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19